0
0
0
A bill to facilitate the development of treatments for cancers, and for other purposes.
2/27/2025, 11:56 AM
Summary of Bill S 755
Bill 119 s 755, also known as the "Cancer Treatment Facilitation Act," aims to streamline the process for developing new treatments for various types of cancer. The bill includes provisions to improve coordination between government agencies, research institutions, and pharmaceutical companies in order to expedite the research and development of innovative cancer therapies.
One key aspect of the bill is the establishment of a task force dedicated to identifying barriers to cancer treatment development and recommending solutions to overcome these obstacles. This task force will be composed of experts from the fields of oncology, pharmacology, and regulatory affairs, among others.
Additionally, the bill includes measures to increase funding for cancer research and clinical trials, with a focus on promoting collaboration between public and private entities. This funding will support the development of new drugs, therapies, and diagnostic tools for cancer patients. Overall, Bill 119 s 755 seeks to enhance the efficiency and effectiveness of the cancer treatment development process, ultimately aiming to improve outcomes for individuals battling cancer. The bill is a bipartisan effort to address the urgent need for innovative treatments in the fight against cancer.
One key aspect of the bill is the establishment of a task force dedicated to identifying barriers to cancer treatment development and recommending solutions to overcome these obstacles. This task force will be composed of experts from the fields of oncology, pharmacology, and regulatory affairs, among others.
Additionally, the bill includes measures to increase funding for cancer research and clinical trials, with a focus on promoting collaboration between public and private entities. This funding will support the development of new drugs, therapies, and diagnostic tools for cancer patients. Overall, Bill 119 s 755 seeks to enhance the efficiency and effectiveness of the cancer treatment development process, ultimately aiming to improve outcomes for individuals battling cancer. The bill is a bipartisan effort to address the urgent need for innovative treatments in the fight against cancer.
Congressional Summary of S 755
Finn Sawyer Access to Cancer Testing Act
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Current Status of Bill S 755
Bill S 755 is currently in the status of Bill Introduced since February 26, 2025. Bill S 755 was introduced during Congress 119 and was introduced to the Senate on February 26, 2025. Bill S 755's most recent activity was Read twice and referred to the Committee on Finance. as of February 26, 2025
Bipartisan Support of Bill S 755
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
1Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 755
Primary Policy Focus
Alternate Title(s) of Bill S 755
A bill to facilitate the development of treatments for cancers, and for other purposes.
A bill to facilitate the development of treatments for cancers, and for other purposes.
Comments
Sponsors and Cosponsors of S 755
Latest Bills
A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Republic of Cuba that have not been authorized by Congress.
Bill SJRES 124May 4, 2026
Safe Tracks Act
Bill HR 8410May 4, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Air Plan Disapproval; Colorado; Regional Haze Plan for the Second Implementation Period".
Bill SJRES 139May 4, 2026
DATA Act of 2026
Bill HR 8400May 4, 2026
Maverick Act
Bill S 4161May 4, 2026
Unhoused Persons Bill of Rights
Bill HRES 1249May 4, 2026
STOP Resolution
Bill HRES 1237May 4, 2026
Encouraging greater public-private sector collaboration to promote financial literacy for students and young adults.
Bill HRES 1238May 4, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Bulletin 2015-07 re: in-person collection of consumer debt".
Bill HJRES 166May 4, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Equal Credit Opportunity (Regulation B); Revocations or Unfavorable Changes to the Terms of Existing Credit Arrangements".
Bill HJRES 164May 4, 2026